NCT00542984View on ClinicalTrials.gov

Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

November 30, 2004

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

teriparatide 20 micrograms/day subcutaneous

DRUG

salmon calcitonin 100 IU/day subcutaneous

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seoul

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00542984 - Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis | Biotech Hunter | Biotech Hunter